Stock info Moderna Inc | Filter Basic-Info
Stock: Moderna Inc (US broad)
| Last Price | 28.54 | Max Price | 122.50 |
| Min Price | 25.13 | 1 Year return | -84.11 |
| Sector | Health Care | Subsector | Biotechnology |
Loading...
Contact info:Country: USA
Sector Review Moderna Inc
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 60 | 141,925 | 0.04 % |
| 2020 | 803 | 170,231 | 0.47 % |
| 2021 | 18,471 | 252,886 | 7.30 % |
| 2022 | 19,263 | 238,496 | 8.08 % |
| 2023 | 0 | 0 | 0.00 % |
Advice Moderna Inc
No Records Found
News Moderna Inc
Moderna to increase doses per vial as U.S. COVID-19 vaccination ramps up
Moderna (NASDAQ:MRNA) has asked permission from the U.S. FDA to increase the number of doses per vial in its COVID-19 vaccine to 15 from 10, CNBC reported citing a person familiar with the matter.
If approved, the change will allow the company to easethe...
Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)
Acceleration in rate of COVID-19 disease across trial sites; Company expects more than 53 cases will be submitted to Data Safety Monitoring Board
for the first interim analysis
Nov. 11, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger...
Analysts expect over 2020 rising revenue Moderna Inc
For this year the company, based inCambridge revenue will be around 309,22 million USD. This is according to the average of the analysts' estimates. This is hugely more than 2019's revenue of 60,21 million USD. Historical revenues and results Moderna Inc plus...
Annual reports Moderna Inc
No Records Found
Profile Moderna Inc
No Records Found
Results Moderna Inc
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
0
|
108
|
206
|
135
|
60
|
803
|
| Costs |
0
|
339
|
476
|
537
|
574
|
1,550
|
| Profit |
0
|
-230
|
-270
|
-402
|
-514
|
-747
|
| Margin of profit |
0.0
|
-212.46
|
-131.10
|
-297.52
|
-853.71
|
-92.99
|
| ROI |
0.0
|
-27.36
|
-43.15
|
-26.26
|
-43.75
|
-29.17
|
Balance Moderna Inc
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
0
|
842
|
625
|
1,530
|
1,175
|
2,561
|
| Debt |
0
|
575
|
459
|
432
|
415
|
4,775
|
| Total assets |
0
|
1,417
|
1,084
|
1,962
|
1,589
|
7,337
|
| Solvency |
0.0
|
59.40
|
57.66
|
77.99
|
73.91
|
34.91
|
| Cash |
0
|
1,058
|
756
|
1,521
|
1,103
|
4,608
|
| Cashflow |
0
|
67
|
-331
|
-331
|
-459
|
2,027
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.0
|
0.12
|
-0.72
|
-0.77
|
-1.11
|
0.42
|
Details Moderna Inc
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
15.27
|
19.56
|
| Eps |
-0.71
|
-0.83
|
-1.22
|
-1.55
|
-1.96
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
-9.85
|
-14.56
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
2.60
|
1.93
|
4.65
|
3.49
|
6.42
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.23
|
0.23
|
| Cashflow per stock |
0.21
|
-1.02
|
-1.01
|
-1.36
|
5.08
|
| Stocks |
324
|
324
|
329
|
337
|
399
|
| Market Cap |
0.00
|
0.00
|
0.00
|
5.138.92
|
11.381.41
|
Dividend Moderna Inc
Price info Moderna Inc
|
Date
|
Price
|
|---|---|
|
01 May 2025
|
28.54
|
|
29 Apr 2025
|
27.46
|
|
22 Apr 2025
|
25.13
|
|
03 Apr 2025
|
27.72
|
|
30 Mar 2025
|
31.12
|
|
15 Mar 2025
|
34.62
|
|
12 Mar 2025
|
33.76
|
|
01 Mar 2025
|
30.96
|
|
25 Feb 2025
|
33.90
|
|
23 Feb 2025
|
35.53
|
|
18 Feb 2025
|
32.99
|
|
13 Feb 2025
|
30.54
|
|
12 Feb 2025
|
30.93
|
|
07 Feb 2025
|
33.61
|
|
05 Feb 2025
|
34.17
|
|
02 Feb 2025
|
39.42
|
|
21 Jan 2025
|
34.06
|
|
17 Jan 2025
|
33.76
|
|
09 Jan 2025
|
43.17
|
|
17 Dec 2024
|
41.84
|
|
10 Dec 2024
|
45.65
|
|
06 Dec 2024
|
42.94
|
|
03 Dec 2024
|
44.26
|
|
29 Nov 2024
|
43.39
|
|
13 Nov 2024
|
43.47
|
|
08 Nov 2024
|
50.28
|
|
05 Nov 2024
|
53.54
|
|
31 Oct 2024
|
54.72
|
|
29 Oct 2024
|
54.80
|
|
23 Oct 2024
|
53.40
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 